MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buller, A. L.
Right arrow Articles by Fraser, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buller, A. L.
Right arrow Articles by Fraser, C. M.

Site-directed mutagenesis of N-linked glycosylation sites on the gamma- aminobutyric acid type A receptor alpha 1 subunit

AL Buller, GA Hastings, EF Kirkness and CM Fraser

Department of Pharmacology, University of Nebraska Medical Center, Omaha 68198.

Oligonucleotide-directed mutagenesis was used to mutate the two potential sites for N-linked glycosylation on the rat gamma- aminobutyric acid (GABA)A receptor alpha 1 subunit. Wild-type (WT) or mutant alpha 1 subunits [asparagine to glutamine substitutions at position 10 (alpha 1Q10), 110 (alpha 1Q110), or both 10 and 110 (alpha 1Q10/110)] were coexpressed with beta 1 and gamma 2 subunits in Xenopus oocytes. Removal of either one or both potential sites for N-linked glycosylation resulted in expression, in Xenopus oocytes, of functional GABAA receptors with pharmacological properties similar to those observed for the WT receptor. WT and mutant alpha 1 subunits were co- transfected with beta 1 and gamma 2 subunits in human embryonic kidney 293 cells. WT and mutant alpha 1 subunits expressed in 293 cells were photoaffinity labeled with [3H]flunitrazepam. Co-transfection of alpha 1WT, alpha 1Q10, or alpha 1Q110 subunits in combination with beta 1 and gamma 2 GABAA receptor subunits resulted in the labeling of single bands, with approximate molecular masses of 54, 49, and 50 kDa, respectively. The decrease in molecular mass for both the alpha 1Q10 and alpha 1Q110 mutants suggests that both consensus sequences for N- linked glycosylation are used in 293 cells. Low levels of [3H]flunitrazepam binding prevented visualization of the alpha 1Q10/110 double mutant. The 293 cells transfected with either the alpha 1Q10 or alpha 1Q110 mutant in combination with beta 1 and gamma 2 subunits expressed significantly lower levels of [3H]Ro15-1788 binding, relative to WT levels. In addition, [3H]Ro15-1788 binding was undetectable in 293 cells expressing the alpha 1Q10/110 double mutant. When transfected 293 cells were grown at 30 zero, [3H]Ro15-1788 binding to alpha 1Q10 and alpha 1Q110 GABAA receptors was restored to levels comparable to that for WT receptors. [3H]Ro15-1788 binding to alpha 1Q10/110 was not reliably detected at 30 zero. Similar results were observed using [3H]muscimol. These data suggest that intracellular processing and transport of the glycosylation-deficient GABAA receptor alpha 1 subunit is temperature sensitive. Furthermore, the observed differences between the two expression systems may be accounted for by the typically lower temperature used for maintaining microinjected Xenopus oocytes. Thus, although glycosylation is not an absolute requirement for GABAA receptor expression, it has a profound effect on the processing of at least the alpha 1 receptor and its subsequent assembly into a mature receptor.

Volume 46, Issue 5, pp. 858-865, 11/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. A. Bradley, C. Taghibiglou, G. L. Collingridge, and Y. T. Wang
Mechanisms Involved in the Reduction of GABAA Receptor {alpha}1-Subunit Expression Caused by the Epilepsy Mutation A322D in the Trafficking-competent Receptor
J. Biol. Chem., August 8, 2008; 283(32): 22043 - 22050.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Gallagher, W. Shen, L. Song, and R. L. Macdonald
Endoplasmic Reticulum Retention and Associated Degradation of a GABAA Receptor Epilepsy Mutation That Inserts an Aspartate in the M3 Transmembrane Segment of the {alpha}1 Subunit
J. Biol. Chem., November 11, 2005; 280(45): 37995 - 38004.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. X. Connor, A. J. Boileau, and C. Czajkowski
A GABAA Receptor alpha 1 Subunit Tagged with Green Fluorescent Protein Requires a beta  Subunit for Functional Surface Expression
J. Biol. Chem., October 30, 1998; 273(44): 28906 - 28911.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. H. Gorrie, Y. Vallis, A. Stephenson, J. Whitfield, B. Browning, T. G. Smart, and S. J. Moss
Assembly of GABAA Receptors Composed of alpha 1 and beta 2 Subunits in Both Cultured Neurons and Fibroblasts
J. Neurosci., September 1, 1997; 17(17): 6587 - 6596.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Sugiyama, A. E. Boyd, and P. Taylor
Anionic Residue in the alpha -Subunit of the Nicotinic Acetylcholine Receptor Contributing to Subunit Assembly and Ligand Binding
J. Biol. Chem., October 25, 1996; 271(43): 26575 - 26581.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. N. Connolly, B. J. Krishek, B. J. McDonald, T. G. Smart, and S. J. Moss
Assembly and Cell Surface Expression of Heteromeric and Homomeric [IMAGE]-Aminobutyric Acid Type A Receptors
J. Biol. Chem., January 5, 1996; 271(1): 89 - 96.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics